In Morocco, the group produces a wide range of medicines that meet the needs of specialties such as oncology, gastroenterology, gynecology, urology, rheumatology, among others, according to a statement from the ZEE to which VerAngola had access.
According to Mohamed Tazi, executive director of the Sothema group, his organization's main interest is to expand its production to southern Africa, promising to install its first factory in Angola in the coming months, after negotiations with AIPEX.
In the ZEE, the group's executives visited the Medvida factory, a unit that manufactures and exports hospital supplies, namely bandages and gauzes, and concluded their visit at the Investor Support Desk (GAI), where they were received by the members of the Board of Directors. of the ZEE.
The CEO of ZEE and AIPEX, António Henriques da Silva, presented the benefits and incentives of this area, as well as the reforms implemented by the Executive in the last four years, aiming to create better conditions for national and foreign investors.
The ZEE concentrates around 130 business units in different sectors, namely: industry, commerce, logistics and the provision of services that guarantee employment to more than six thousand workers.
Sothema continues its expansion path, having been boosting the Senegalese pharmaceutical industry through the creation of the subsidiary West Afric Pharma, in Dakar. The objective is to facilitate access to medicines for African populations. The medicines manufactured by WAPH are generics intended for the treatment of the most widespread diseases in the region: malaria, chronic diarrhea and cholera.
